In Westernized societies, average consumption of n-6 polyunsaturated fatty acids (PUFAs) far exceeds nutritional requirements. The ratio of n-6 to n-3 PUFAs is generally >10:1 whereas on a primitive human diet it was closer to 1:1. Diets fed to intensively farmed livestock have followed a similar trend. Both n-6 and n-3 PUFAs can influence reproductive processes through a variety of mechanisms.

They provide the precursors for prostaglandin synthesis and can modulate the expression patterns of many key enzymes involved in both prostaglandin and steroid metabolism. They are essential components of all cell membranes. The proportions of different PUFAs in tissues of the reproductive tract reflect dietary consumption. PUFA supplements (particularly n-3 PUFAs in fish oil) are promoted for general health reasons.

Fish oils may also benefit fertility in cattle and reduce the risk of preterm labor in women, but in both cases current evidence to support this is inconclusive. Gammalinolenic acid containing oils can alter the types of prostaglandins produced by cells in vitro, but published data to support claims relating to effects on reproductive health are lacking.

Spermatozoa require a high PUFA content to provide the plasma membrane with the fluidity essential at fertilization. However, this makes spermatozoa particularly vulnerable to attack by reactive oxygen species, and lifestyle factors promoting oxidative stress have clear associations with reduced fertility. Adequately powered trials that control for the ratios of different PUFAs consumed are required to determine the extent to which this aspect of our diets does influence our fertility.

Fats and oils together comprise more than 33% of the daily calorific intake of the American human diet [1]. These include both saturated fatty acids (SFA) and mono- and polyunsaturated fatty acids (MUFA and PUFA, see Tables 1 and 2 for summary abbreviations used).

Animals cannot synthesize n-6 or n-3 fatty acids de novo as they lack the appropriate fatty acid desaturase enzymes.The n-6 PUFA linoleic acid (LA) and the n-3 PUFA a-linolenic acid (ALA) therefore need to be provided in the diet as they are absolutely necessary for numerous processes, including growth, reproduction, vision, and brain development [2].

FIGURE 1: Scheme to illustrate the generation of 1-, 2-, and 3-series prostaglandins (PGs) from dietary polyunsaturated fatty acids.

PUFAs and PROSTAGLANDINS

Twenty carbon PUFAs are the direct precursors of a large group of physiologically active compounds called eicosanoids which include prostaglandins (PGs), thromboxanes, leukotrienes and lipoxins [10]. The 1- and 2-series PGs are derived from the n-6 PUFAs DGLA and AA respectively, whereas the 3-series PGs are derived from EPA (the n-3 equivalent of AA) (Fig. 1) [10].

The synthesis of PGs in tissues throughout the body is a very tightly regulated process. Excess PUFAs are 'stored' in most cells within phospholipids in the membranes in an esterified form. The initial step is the generation of the PUFA substrate within the cell (e.g., AA for 2-series PGs). AA is liberated by the action of a phospholipase A2 (PLA2). Many phospholipases have been identified, of which intracellular Group IV cytosolic A2a (GIVA) appears most important in controlling the availability of free AA for PG synthesis [11].

Activation of cytosolic PLA2 is dependent on release of stored calcium from the endoplasmic reticulum, leading in turn to activation of protein kinase C [12]. The free AA (or other PUFA) generated is then metabolized by prostaglandin endoperoxide synthase (PTGS) enzymes, of which PTGS1 and PTGS2 are most relevant to reproductive biology (Fig. 2). Although PTGS1 and PTGS2 fulfill the same function, they are encoded by different genes, regulated differentially, expressed in a cell specific manner, and found in different subcellular compartments [13].

The PTGS enzymes provide PGH to PG synthases in a spatially segregated manner [13]. Two forms of PGE synthase (PTGES) have been identified, of which the inducible form PTGES1, located in the microsomal fraction, is the enzyme responsible for PGE₂ output in inflammatory situations [14]. There are multiple isoforms of PGF synthases belonging to the aldoketoreductase family [15, 16]. These will be referred to collectively as PGFS.

PGs act through cognate G-protein-coupled receptors (e.g.,EP, FP) [17, 18]. To date, four subtypes of the prostaglandin E receptor (PTGER) have been cloned (PTGER1, PTGER2,PTGER3, PTGER4), with multiple isoforms of the PTGER3 receptor subtype [17]. Activation of PTGER receptors can result in an increase in [Ca²⁺]_i (via PTGER1 receptors),phosphoinositol turnover (via PTGER3 receptors), cAMP generation (via PTGER2 and PTGER4 receptors), or inhibition of agonist-stimulated adenylate cylcase activity (via PTGER3 receptors) [18 and references therein].

While this summarizes the typical second messenger responses mediated via PTGER receptors, it must be emphasized that the coupling of a given receptor subtype can vary dramatically between tissues and between species. Due to the similarities in structure between different PG molecules, there is some cross-reactivity of different PGs between receptors. The 2-series PGs are generally considered to be more biologically active than the 1- and 3-series PGs.

For example, PGF_2a had a 10-fold greater potency compared to PGF_3a in protecting against ethanolinduced injury to the gastric mucosa in rats [19]. In bovine luteal cells, PGF_3a had a relatively high affinity for the PGF receptor (PTGFR) (39 nM versus 10 nM for PGF_2a), as compared to PGF1a, whose affinity was considerably lower (153 nM versus 10 nM for PGF_2a) [20].

On the other hand, in Chinese hamster ovary cells expressing different PTGES receptor subtypes, PGE₁ and PGE₂ had very similar K_i values for all four receptor subtypes (e.g., about ~12 nM for the PTGER2 receptor) [21]. The binding characteristics of PGE₁ and PGE₂ to PTGER3 receptors in bovine luteal cells were also similar [22]. On the other hand, PGE1 acting through the PTGER2 or PTGER4 was more effective than PGE₂ at inhibiting vascular smooth muscle cell proliferation [23]. It is therefore unwise to assume that the 2-series PGs are always more potent than their 1- and 3-series equivalents.

PUFA EFFECTS ON PG SYNTHESIS

PUFAs affect PG production by acting as substrates for, and competitive inhibitors of, cyclooxygenation and by altering expression or cellular concentrations of the various relevant enzymes. The proportion of different PUFAs in the diet alters cell membrane phospholipid composition and this becomes quantitatively significant because the precursors of each group of PGs compete for the same enzyme systems for metabolism [24].

This in turn will have considerable effects on the types of PG synthesized-and hence, physiological responses [25]. For example, in our studies on PG synthesis in the ruminant uterus, LA added in vitro was generally inhibitory. Either in vivo supplementation of an LA enriched diet to cattle [26] or in vitro supplementation of LA to endometrial cells isolated from late pregnant ewes also caused a significant decrease in production of 2-series PGs [27].

In contrast, feeding a diet high in LA to late pregnant ewes increased endometrial and placental PG production [28-30]. This was associated with an approximate 50% increase in AA concentrations in blood and caruncular endometrium, suggesting that in this case, effective metabolism of LA to AA had occurred, thus providing more precursor. In support of this, supplementation of cultured endometrial cells with GLA or AA significantly increased PG synthesis [27].

Affinities for precursors (substrates) decreases from the n-3 to the n-9 series PUFAs, thus when EPA is present in sufficient amounts, it can depress metabolism of n-6 PUFAs and hence the synthesis of the 2-series PGs. The preferred substrate for PTGS catalysis by either PTGS1 or PTGS2 is AA [31]. Although EPA is a substrate for both PTGS1 and PTGS2, its metabolism via PTGS1 is poor (about 10% that of AA), which means that its ability to generate 3-series PGs is also poor [31].

EPA is also an inhibitor of PTGS1 activity. This means that EPA not only inhibits 2-series PG generation (for example, in cultured bovine endometrial cells [32]), but does not induce, as expected, a concomitant increase in 3-series PG generation via PTGS1. Despite this, changes in the synthesis of 3-series PGs do occur following dietary supplementation with n-3 PUFAs in man [33].

As well as altering the proportions of 1-, 2-, and 3-series PGs produced, there is also evidence PUFAs can influence the balance between the production of PGF and PGE. We found that supplementing cultured ovine endometrial cells with the n-6 PUFAs LA, GLA, or AA all resulted in a significant shift to the production of more PGE₂ relative to PGF_2a [27].

Beef heifers fed a high fish oil diet had a higher mRNA expression of PTGES in the endometrium [34], suggesting a possible mechanism for this effect. On the other hand, dairy cows receiving chronic feeding of bypass calcium salts of fish oil (enriched in EPA and DHA) did not have altered PTGS2, PTGES, or PGFS mRNA expression in endometrial tissue collected at Day 17 of the cycle [35].

PUFAs AND STEROIDOGENESIS

AA and its metabolites have long been implicated in steroidogenesis through direct effects on the steroidogenic machinery (e.g., steroid acute regulator [STAR] protein, cytochrome P450, family 11, sub family A, polypeptide 1 enzyme [CYP11A1]), or indirect effects via PGs. STAR plays a critical role in regulating steroid synthesis [36].

In MA-10 Leydig cells, inhibition of endogenous release of AA inhibited dibutyryl cAMP-induced steroid synthesis as well as STAR promoter activity, Star mRNA and STAR protein, whereas addition of exogenous AA reversed all these effects. Specific inhibition of PTGS2 was also associated with an increased Star expression and steroid output [37, 38].

This may be caused by a decrease in PGF2a, as the latter inhibits STAR protein expression, consistent with its well-established role in inhibiting luteal progesterone synthesis [38]. In contrast, the age-dependent inhibition of testosterone production involves the suppression of STAR as a consequence of oxidative stress [39]. The cause of the latter is not known for certain, but is correlated with excessive AA flux through the PTGS2 pathway [40], possibly promoted by an age-dependent leakage of electrons from Leydig cell mitochondria [41].

PUFAs can also regulate adrenal steroidogenesis. Basal corticosterone synthesis was stimulated by LA [42] while ACTH-stimulated steroid synthesis was inhibited [43]. We have similarly shown that n-3 and n-6 PUFAs in vitro stimulated cortisol secretion by ovine adrenocortical cells [44].

Supplementation of ewes with a high n-3 PUFA diet (ALA) prior to tissue collection abolished this ability to respond to further PUFA additions in vitro. These changes in steroid synthesis and responsiveness were accompanied by changes in STAR protein and mRNA expression. The ability of PTGS metabolites of AA such as PGE₂ to apparently mediate the stimulatory effects of ACTH on corticosterone secretion in the rat adrenal cortex [45] provides further evidence that PUFAs and eicosanoids modulate steroid synthesis in a variety of different steroidogenic tissues.

PUFAs AND TRANSCRIPTION FACTORS

PUFAs may also alter the function of transcription factors controlling gene expression and can thus affect cellular concentrations of enzymes regulating both the PG and steroidogenic synthetic pathways. For example, upstream transcription factor proteins (USF-1 and USF-2) affect PTGS2 promoter activation [46].

Moreover, protein kinase A-dependent phosphorylation of USF enhances its ability to transactivate PTGS2 [47]. In luteinised granulosa cells and in bovine endometrial stromal cells, both n-6 and n-3 PUFAs activate protein kinase C, which in turn phosphorylates and activates phosphodiesterase [48, 49].

Therefore PUFAs should reduce USF-2 phosphorylation and PTGS2 transactivation through this effect. Given that PUFAs can activate mitogenactivated protein kinase 3 (MAPK3) [50], it is also possible that they could regulate PTGES2 and PTGS2 activation in a MAPK-dependent manner [51]. This raises the possibility that PUFAs could affect the activity of an enzyme such as PTGS2 through altered phosphorylation even when the absolute protein concentrations remain unchanged.

In relation to steroidogenesis, nuclear receptor subfamily 1, group H, member 3 (NR1H3) is a transcription factor known to respond to PUFAs [52] that affects expression of STAR, and therefore steroid synthesis in mouse adrenocortical cells [53]. NR1H3 is also present in the ovine ovary [54]. In addition to these factors, PUFAs affect another class of transcription factors, the peroxisome proliferator activated receptors (PPARs).

PPARs are a family of nuclear receptors that are activated by endogenous ligands such as PUFAs [52]. A detailed discussion of PPARs and the consequences of possible interactions with PUFAs is beyond the scope of this review. It is, however, pertinent to draw the readers' attention to this class of molecules, as PPARs can affect many aspects of reproduction including gonadal steroid synthesis [55] and parturition [56].

PUFAS AND MEMBRANE PROPERTIES

Dietary treatment of mice with either EPA or DHA suppressed mitogen induced T-lymphocyte proliferation by inhibiting interleukin-2 (IL-2) secretion [57]. In investigating a possible mechanism for this response, the authors showed that the 3-series PUFAs (but not AA) affected the kinetics of two important intracellular second messengers, diacyglycerol (the physiological activator of protein kinase C) and ceramide. In cultured ovine uterine epithelial cells treated with either GLA or AA, PG production was up-regulated, but the cells became unresponsive to oxytocin [27, 58].

Whilst it is possible that this reflected saturation of available PTGS2, an alternative explanation could be due to alterations in cell signaling pathways. Previous workers showed that the myometrial oxytocin receptor could be converted from a low to a high affinity state by the addition of cholesterol, an effect thought to be mediated via changes in membrane properties [59].

These experimental findings raise the possibility that PUFAs may also differentially affect cellular responses through changes in membrane fluidity, receptor binding characteristics or their downstream activation.

THE ESTABLISHMENT OF PREGNANCY IN RUMINANTS

The establishment of pregnancy in ruminants requires ovulation of a competent oocyte, insemination at the correct time and an appropriate pattern of estradiol and progesterone during the follicular and luteal phases of the estrous cycle [60, 61].

Furthermore, the embryo must develop adequately to prevent luteolysis by the production of sufficient interferon_T to inhibit up-regulation of endometrial oxytocin receptors [62]. In dairy cattle there is extensive loss of embryos over this period, so that only around 40% of cows remain pregnant 28 days after insemination [63].

There is some evidence that all of these events can be influenced by dietary PUFAs. Oocytes of many species contain high levels of fatty acids (FAs) [64]. Granulosa cell and oocyte FAs were more saturated than those of plasma, suggesting a selective uptake mechanism in follicles [65].

FAs are used as an energy source during oocyte maturation and the extended period of embryo development before implantation. Bovine oocytes exposed to methyl palmoxirate to block FA oxidation showed reduced capacity to form blastocysts after fertilization [66].

The PUFA content of oocytes can affect maturation, cryopreservation and subsequent developmental competence. ALA has been implicated in oocyte growth and differentiation, in regulating meiotic arrest at the germinal vesicle stage, and in preventing germinal vesicle breakdown [67, 68].

Higher numbers of grade 1 oocytes were collected from n-3 PUFA supplemented ewes [69]. Differences in FA composition between grade 1 and grade 2/3 oocytes suggests that these may be important for oocyte competence as well as fertilization and developmental potential [68]. However, feeding PUFAs (vegetable or linseed oils) in comparison with MUFAs to lactating dairy cows failed to affect oocyte quality, assessed by embryo development after IVF [70].

In cattle, dietary supplementation with various long chain PUFAs (both n-3 and n-6) induced changes in several aspects of folliculogenesis, including both an increase in total follicular numbers and in the size of the dominant or pre-ovulatory follicle [70-74].

In contrast, Petit et al. [75-76] found little or no effect of linseed, fish oil, flax, and sunflower seed supplemented diets on follicular dynamics. Granulosa cells collected from follicles of n-6 PUFA supplemented cows showed increased steroid secretion in vitro [77] and follicular phase estradiol concentrations were higher in cows supplemented with ALA [78].

Dietary PUFAs have influenced several aspects of luteal function in some but not all studies. Cows on diets high in LA had decreased progesterone levels (;50%) on Days 4 through 8 of the estrous cycle while cows on a high ALA diet had decreased levels of progesterone on Days 4 through 15 of the cycle [78]. This suggested that n-3 or n-6 PUFAs either directly or indirectly (via PGs) exerted differential effects on ovarian steroid synthesis.

The finding that n-3 PUFAs in vitro inhibited bovine luteal cell progesterone secretion supported this contention [79]. Other workers, however, found no changes in luteal progesterone secretion following diets containing flaxseed (mainly n-3) or sunflower seed (n-6) [74], Menhaden fish meal [80], or fish oil [73].

PGs are thought to act as luteotrophic factors in the early luteal phase. PGE₂ stimulated progesterone secretion by cyclic corpora lutea whereas in the corpora lutea of pregnancy, PGE₁ was more potent than PGE₂ in stimulating progesterone secretion [81].

Later in the cycle, PGF_2a is the main luteolytic agent [12]. There is evidence that n-3 PUFAs (e.g., ALA and EPA) can inhibit PGF2a release by bovine endometrial cells [82]. In support of this, we have shown that a high n-3 diet (ALA) can delay luteal regression in cyclic ewes through delaying the onset of pulsatile release of PGF_2a [83].

In contrast, a number of trials conducted on cattle that have measured the amount of the PGF metabolite 13,14-dihydro-15- keto-PGF_2a (PGFM) released in response to an oxytocin challenge given in the late luteal phase have produced conflicting results. On Day 15 of the cycle, Mattos et al. [80] reported reduced PGFM secretion in cows fed fish meal, but Petit et al. [75] found a higher response in cows given a mixture of linseed and fish oil compared with linseed alone.

Petit et al. [76] reported a trend to higher PGFM on Day 15 on a diet supplemented with sunflower seed compared with flaxseed or Megalac. Robinson et al. [78] found no effect of LA- or ALA-based diets on Days 15 and 16 of the cycle, but on Day 17 cows on the LA diet had a higher response to oxytocin.

These results suggest that dietary changes involving PUFAs can influence the PGFM response, but no consistent pattern has emerged. This may in part be due to the fact that the amount of PGFM released in response to oxytocin increases as the time of natural luteolysis approaches, so treatment differences may be confounded by slight changes in cycle length between animals.

Changes to the progesterone profile during the estrous cycle outlined above would be likely to affect early embryo development indirectly. Decreased progesterone concentrations in the early luteal phase in cattle reduce embryo survival, an effect thought to be mediated via changes in uterine secretions [84].

On the other hand, the ability of n-3 PUFA supplements to delay luteolysis has been proposed as a potential method of improving cattle fertility by giving the conceptus longer to develop before the onset of luteolysis [85]. A number of trials conducted over the past 20 years suggest that feeding fishmeal to cattle improves the conception rates [86-89].

However, results often did not achieve statistical significance and these data are far from conclusive at present. The two earlier studies [86, 87] failed to control for the level of protein in the feed, which was also increased, and in the study of Burke et al. [88] fertility was only improved in one of two dairies included in the trial, in which overall fertility was poor. Other studies have examined the effect of flaxseed on conception in cattle.

Two earlier trials reported lower pregnancy losses in cows fed flaxseed [74, 90], but this effect was not repeated when larger numbers of cows were examined [91]. In order to detect a 10% difference in pregnancy rate with a power of 0.8 at P < 0.05, a minimum of 300 animals per group is required. These conditions have not been met in work conducted to date, so more large-scale, well-controlled trials are required to resolve this issue.

GLA AND THE CONTROL OF UTERINE ACTIVITY IN WOMEN

Oils containing high concentrations of GLA (e.g., evening primrose and borage oil) have known anti-inflammatory properties, an effect thought to be mediated at least in part via increased production of PGE₁ [23]. These products are promoted widely to the female population through health food shops and the Internet for a variety of reasons relating to reproduction.

These include enhanced sperm transport for couples wishing to conceive, as GLA is said to aid sperm survival through improvements to the nature of cervical mucus [92]. Opinion is divided as to whether GLA containing oils increase uterine contractions, thus leading to induction of labor [93], or decrease them, resulting in relief of some symptoms of premenstrual tension [94].

LA can be metabolized into GLA by FADS2, but in practice only a small fraction of dietary LA is converted to GLA as this enzyme is highly rate-limiting (Fig. 1) [5, 23]. Previous work in various cell types indicates that supplemented GLA bypasses this step and is quickly elongated to DGLA [23, 95].

Due to the further rate-liming properties of fatty acid desaturase 1 (FADS1), only a small portion of DGLA can be converted into AA and the accumulated DGLA is converted into 1-series PGs by PTGS [23, 96]. Both Fads2 and Fads1 are highly expressed in liver, where expression is regulated by a variety of nutritional stimuli including composition of dietary fat [97-99].

Most PUFA metabolism is therefore likely to occur at this level following dietary consumption. The enzymatic activity of FADS2 is reportedly lower in other tissues, although significant expression is present elsewhere, for example in lung, heart, and skeletal muscle [97]. Fads1 expression likewise has a wide distribution including the placenta, but with a much lower abundance than Fads2 [98].

There is surprisingly little published data available to support the contention that GLA consumption modulates aspects of reproduction. Our studies based on ovine uterine epithelial cells confirmed that addition of GLA in vitro increased both the absolute and proportional PGF1a production and slightly enhanced PGF_2a generation, whereas supplemental AA increased PGF_2a generation as expected [58].

Both GLA and AA increased overall PGF output significantly but prevented the cells from responding to oxytocin. GLA treatment of isolated rat uterine strips similarly enhanced the output of PGE₁ but did not influence the generation of PGE₂ or PGF_2a [100].

As the PUFAs in both experiments were added directly to the uterine tissues, these data suggest indirectly that elongase activity is present in uterus but that FADS1 expression is low or absent. There is, however, little known about how much PGF1a is produced by normal reproductive tissues with or without GLA supplementation, or what the biological effects of PGF1a are in the context of reproduction.

PGF_1a was unable to decrease luteal progesterone concentrations in bovine corpora lutea in vitro [101] and it did not cause luteolysis in pregnant rats, although there was evidence of intrauterine growth retardation [102]. This is consistent with its lower affinity for the PGF receptor in comparison with PGF_2a [20].

Endometrial biopsies from women taking a 6-month dietary supplement of GLA had a reduced ability to synthesize PGF_2a and PGE₂ in vitro, but 1-series PGs were not measured [103]. Intravenous infusion of PGF_1a to one woman induced labor, but it was estimated to be 10 times less potent that PGE1 in this respect [104].

An evening primrose oil supplement was also evaluated in relation to fertility in the blue fox. It tended to improve the conception rate but the abortion rate also increased, so there was no overall effect on the number of females producing litters [105]. Further studies to determine the relevance of 1-series PGs to reproductive processes are thus urgently required.

PUFAs AND PRETERM LABOR

Preterm birth occurs in about 10% of all human pregnancies and is associated with 70% of neonatal deaths [106]. Spontaneous preterm labor is a worldwide problem that affects countries regardless of economic status. In most eutherian mammals, it is largely accepted that changes in the hypothalamo-pituitary-adrenal axis are responsible for initiating the onset of parturition [107].

This was originally demonstrated in sheep, where a rise in fetal cortisol initiates a chain of events that culminates in the birth of the offspring. The main action of cortisol in the context of parturition is to raise levels of 2-series PGs [106, 108]. Both fetal and maternal tissues, including amnion, chorion, and decidual endometrium, synthesize PGs in vitro [107].The levels of PGs along with their synthetic enzymes (mainly PTGS2) increase either before or at the time of labor and inhibitors of PG synthesis prolong gestation [108].

PUFAs may thus be able to influence the timing of parturition through alterations to PG or adrenal steroid synthesis as previously discussed. A diet high in n-6 PUFAs is generally thought to be associated with an increased risk of preterm delivery. Plasma concentrations of AA increase throughout pregnancy, with the highest levels being observed during labor followed by a rapid decline postpartum [109].

The onset of normal labor is associated with increased levels of both LA and AA in blood [110]. Sheep fed a diet rich in n-6 PUFAs during late gestation had higher circulating concentrations of 2-series PGs (PGE₂ and PGF_2a), produced more PGs in uterine and placental tissues, and appeared to be more susceptible to preterm parturition [28-30]. Similar observations have been reported in human subjects, where women who delivered prematurely were shown to possess higher n-6 PUFA concentrations in erythrocytes [111, 112].

In women, low n-3 PUFA consumption during pregnancy is also associated with a higher risk of preterm labor and low birth weight [113]. Conversely, a diet high in n-3 PUFA is associated with an increase in gestational length and birth weight in rats [114-116] and human populations with high fish consumption such as that seen in Faroese women and Greenland Eskimos [117]. In rats, excessive n-3 PUFA consumption during pregnancy was associated with a prolonged and difficult labor [118, 119].

Various mechanisms have been suggested to explain these effects. They could be as a direct result of a shift from synthesis of 2-series to 3-series PGs and significant production of 3-series PGs by rat uterus has been confirmed using mass spectroscopy [120]. In late pregnant sheep, infusion of n-3 PUFAs was shown to inhibit the course of betamethasone- induced labor [121], an effect that was associated with a decrease in myometrial PTGS2 mRNA [122]. Based on ratios of FAs measured in serum phospholipids, Greenland Eskimos also have decreased FADS1 activity, leading to proportionately lower circulating concentrations of AA (see Fig. 1) [123].

These findings have led to the suggestion that dietary supplementation of pregnant women with n-3 PUFAs may be used to diminish the risk of premature delivery in high-risk subjects, as it represents a low-cost, minimally invasive strategy [124]. Some well-powered epidemiological studies have appeared to suggest that such interventions have been successful, with mean increases in gestation length of 4 and 6 days, respectively [125, 126].

Women with a previous preterm delivery had a significantly lower recurrence following EPA and DHA supplementation in comparison with a placebo group, reducing the risk from 33% to 21% [127]. A further trial that provided women with DHA-enriched eggs found fewer low-birth-weight and preterm babies and a larger placental size [128].

In contrast, another large randomized clinical trial with supplemental fish oil in Norwegian women had no effect on either birth weight or gestation length [129]. Furthermore, supplementation of seafood to an American population slowed fetal growth, decreased birth weight, and did not reduce the risk of preterm birth [130].

In their review of this topic, Allen and Harris [7] drew attention to the need for high doses of fish oil in order to obtain an effect and also highlighted the possible differences in action of DHA and EPA. These are hard to separate, as many preparations contain both PUFAs in varying proportions.

The most comprehensive evaluation of the available data to date [131] concluded that results obtained so far are inconclusive and recommended that further interventionist studies be carried out both to assess the efficacy of n-3 PUFA supplementation in preventing prematurity and to understand the mechanistic nature of the PUFA action.

Long chain PUFAs have been detected in the spermatozoa of man [132, 133] and a variety of livestock species including both mammals (ram, bull, boar [134]) and birds (chickens, ducks, turkeys, [135]). In birds, the most abundant were the n-6 PUFAs AA (5%-9%) and docosatetranoic acid (22:4 n-6, 15%-21%). These were synthesized from LA, which was the most abundant PUFA in the diet (15%), but was present at a lower concentration in spermatozoa (2%-3%) [136]. Altering the PUFA sources in the diet resulted in concomitant changes in the n-6 and n-3 composition of sperm (e.g., boar [137], cockerel [138, 139]).

In addition, changes in membrane fluidity could theoretically impede the assembly and activation of signal transduction pathways critical to the fertilization process, although this has not to our knowledge been studied. The propagation of peroxidative damage is catalyzed by the presence of transition metals, such as iron or copper that can change their valency state by gaining or losing electrons.

Measurements of the products of lipid peroxidation, such as malondialdehyde and 4-hydroxyalkenal, have been shown to correlate negatively with semen quality in both man and domestic animals [132, 143, 144]. Reductions in human semen quality as a consequence of smoking, infection, irradiation, varicocele, oligozoospermia, and toxicant/heavy metal exposure have all been linked with oxidative stress and the promotion of lipoperoxidation [145-148].

Similarly, in animal models the adverse reproductive effects of irradiation and xenobiotic exposure have been linked to the induction of peroxidative damage in the spermatozoa. For example, trichloroethylene, a widely used industrial solvent and common water contaminant, has been found to disrupt fertility in male rats as a consequence of oxidative damage to the spermatozoa [148].

FIGURE 2: A proposed mechanism by which unsaturated fatty acids might generate oxidative stress in human spermatozoa. An abundance of unsaturated fatty acids in the spermatozoa of infertile patients triggers free radical generation from a nonmitochondrial source, possibly the NADPH oxidase, NOX5, under the influence of calcium [167]. Excessive reactive oxygen species generation (ROS) then induces lipid peroxidation that, in turn, triggers phospholipase A2, precipitating the release of further unsaturated fatty acids and the induction of yet more ROS generation to perpetuate the oxidative stress.

There is overwhelming evidence that dietary PUFA consumption can alter both the type and amount of PGs produced by different tissues. Dogma predicts that DGLA will increase production of 1-series PGs and that n-3 PUFAs will both reduce overall PG output and alter the balance of production in favor of 3-series PG. While there are good grounds to support this view, hardly any studies related to the reproductive system have actually measured 1- or 3- series PG production, in large part due to limitations over appropriate methodology.

Furthermore, there is also a lack of information on how organs such as the uterus will respond physiologically to different mixtures of the various PGs that may be generated. An additional complication is the growing evidence that PUFAs may also alter the ratio of PGE to PGF produced. While increased supply of AA at a tissue level generally increases the total output of 2-series PGs, this may also limit the ability of the tissue to respond to stimuli such as oxytocin. This effect could be due to limitations on PTGS availability, or to alterations in membrane properties, another topic that awaits study.

In relation to steroidogenesis, most work to date has focused on AA. Again, the evidence is clear that AA can influence steroid output at a cellular level. However, both stimulatory and inhibitory effects have been reported in vitro and responses of animals fed different PUFA diets have also varied considerably. For example, n-3 PUFAs have decreased or had no effect on luteal progesterone output in different studies on cattle.

Reported effects of PUFAs on various aspects of female reproduction are equally unclear. Early enthusiasm for the possibility of using fish oil to improve fertility in cattle or to reduce the risk of preterm labor in women has not always been replicated in later studies. Some investigations have been underpowered. Others have lacked appropriate controls. Responses between individuals clearly vary according to the balance of PUFAs stored in particular tissues.

This is influenced by the immediate life history of the animal and is very difficult to either regulate or measure accurately in human populations. While it is relatively easy to give more of a particular PUFA such as DGLA or DHA, it is harder to design appropriate control diets that are balanced for both protein and energy intake, as all other fats that may be used instead are likely to be bioactive in their own right. There are also real issues over the cost and palatability of some of the supplements, particularly in relation to animal diets.

With regard to male fertility, PUFAs are essential by virtue of their ability to confer upon the sperm plasma membrane the fluidity it needs to achieve fertilization. Moreover, they are critical components of a particular class of fucosylated glycosphingolipids that are essential for male fertility.

They are, however, also a potential source of pernicious alkoxyl and peroxy radicals, should these cells experience oxidative stress as a consequence of the range of factors related to disease status or lifestyle previously discussed. PUFAs have similar dichotomous effects on other aspects of male reproduction such as Leydig cell steroidogenesis. On the one hand, AA can stimulate the production of testosterone via effects on STAR. On the other hand, the age-dependent inhibition of testosterone involves the suppression of STAR as a consequence of oxidative stress, possibly promoted by an age-dependent leakage of electrons from Leydig cell mitochondria.

In conclusion, PUFAs can affect many reproductive processes. As consumers, we are all bombarded with advertisements to alter our diets to promote healthy living. It is widely accepted that fertility of both human and farm animal populations in westernized societies is currently decreasing. However the jury is still out as regards appropriate advice over PUFA consumption. It appears that PUFAs are a two-edged sword-some are essential, but too many are potentially harmful. We remain largely ignorant as to the best balance to take at different points in our lives in order achieve optimum fertility.

1. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States 1988-94. Vital Health Stat 2002; 11: 1-158.

2. Gurr MI, Harwood JL, Frayn KN. Lipid Biochemistry: An Introduction. 5th ed. Oxford, UK: Blackwell Science Ltd.; 2002.

3. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21:495-505.

4. Dickerson LM, Mazyck PJ, Hunter MH. Pre-menstrual syndrome. Am Fam Physician 2003; 67:1743-1752.

5. Fischer S. Dietary polyunsaturated fatty acids and eicosanoid formation in humans. Adv Lipid Res 1989; 23:169-198.

6. Pike IH, Barlow SM. The fats of life - the role of fish. Lipid Technology 2000; 13:58-60.

7. Allen KGD, Harris MA. The role of n-3 fatty acids in gestation and parturition. Exp Biol Med 2001; 226:498-506.

8. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54:438-463.

9. Aitken RJ, Baker HW. Seminal leukocytes: passengers, terrorists or good samaritans? Hum Reprod 1995; 10:1736-1739.

10. Needleman P, Turk J, Kakshik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 1986; 55:69-102.

11. Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res 2006; 45:487-510.

12. Poyser NL. Intracellular processes controlling prostaglandin production by the uterus in relation to luteolysis and menstruation. Trends Reprod Biol 2005; 1:15-28.

13. Smith WL, Lagenbach R. Why there are two cylcooxygenase enzymes. J Clin Invest 2001; 107:1491-1495.

14. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2- biosynthetic pathway. Prog Lipid Res 2004; 43:3-35.

15. Jez JM, Bennett MJ, Schlegel BP, Lewis M, Penning TM. Comparative anatomy of the aldo-keto reductase superfamily. Biochem J 1997; 326:625-636.

16. Madore E, Harvey N, Parent J, Chapdelaine P, Arosh JA, Fortier MA. An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium. J Biol Chem 2003; 278:11205-11212.

17. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46:205-229.

18. Hatta AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004; 103:147-166.

19. Faust TW, Lee E, Redfern JS, Feldman M. Effect of prostaglandin F3 alpha on gastric mucosal injury by ethanol in rats: comparison with prostaglandin F2a. Prostaglandins 1989; 37:493-504.

20. Andersen LE, Wu Y-L, Tsai S-J, Wiltbank MC. Prostaglandin F2a receptor in the corpus luteum: recent information on the gene, messenger ribonucleic acid, and protein. Biol Reprod 2001; 64:1041-1047.

21. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997; 122:217-224.

22. Sharif NA, Xu SX, Williams GW, Crider JY, Griffin BW, Davis TL. Pharmacology of [3H]prostaglandinE1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther 1998; 286:1094-1102.

23. Fan YY, Chapkin RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998; 128:1411-1414.

24. Lands WEM. Biochemistry and physiology of n-3 fatty acids. FASEB 1992; 6:2530-2536.

25. Abayasekara DRE, Wathes DC. Effects of altering dietary fatty acid composition on prostaglandin synthesis and fertility. Prostaglandins Leukot Essent Fatty Acids 1999; 61:275-287.

26. Cheng Z, Robinson RS, Pushpakumara PGA, Mansbridge RJ, Wathes DC. Effect of dietary polyunsaturated fatty acids on uterine prostaglandin synthesis in the cow. J Endocrinol 2001; 171:463-473.

27. Cheng Z, Elmes M, Kirkup SE, Abayasekara DRE, Wathes DC. Alteration of prostaglandin production and agonist responsiveness by n-6 polyunsaturated fatty acids in endometrial cells from late gestational ewes. J Endocrinol 2004; 182:249-256.

28. Elmes M, Tew P, Cheng Z, Kirkup SE, Abayasekara DRE, Calder PC, Hanson MA, Wathes DC, Burdge GC. The effect of dietary supplementation with linoleic acid to late gestation ewes on the fatty acid composition of maternal and fetal plasma and tissues and the synthetic capacity of the placenta for 2-series prostaglandins. Biochim Biophys Acta 2004; 1686:139-147.

29. Elmes M, Green LR, Poore K, Newman J, Burrage D, Abayasekara DRE, Cheng Z, Hanson MA, Wathes DC. Raised dietary n-6 polyunsaturated fatty intake increases 2-series prostaglandin production during labour in the ewe. J Physiol 2005; 562:583-592.

30. Cheng Z, Elmes M, Kirkup SE, Chin EC, Abayasekara DRE, Wathes DC. The effect of a diet supplemented with n-6 polyunsaturated fatty acid (PUFA) linoleic acid on prostaglandin production in early and late pregnant ewes. J Endocrinol 2005; 184:167-178.

31. Smith WL. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 2005; 17:174-182.

32. MacLaren LA, Guzeloglu A, Michel F, Thatcher WW. Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production. Domest Anim Endocrinol 2006; 30:155-169.

33. Hornstra G, van Houwelingen AC, Kivits GA, Fischer S, Uedelhoven W. Dietary fish and prostanoid formation in man. Adv Prostaglandin Thromboxane Leukot Res 1991; 21A:225-228.

34. Waters SM, Child S, Creenan JM, Hennessy AA, Stanton C, Kenny DA. Effect of dietary omega-3 polyunsaturated fatty acids on uterine endometrial gene expression in cattle. 6th ARK-Genomics Farm Animal Functional Genomics Workshop. Cambridge, UK; 2006.

35. Bilby TR, Guzeloglu A, MacLaren LA, Staples CR, Thatcher WW. Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lactating dairy cows: II. Endometrial gene expression related to maintenance of pregnancy. J Dairy Sci 2006; 89:3375-3385.

36. Stocco DM, Wang X, Jo Y, Manna PR. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol Endocrinol 2005; 19:2647-2659.

37. Wang XJ, Dyson MT, Jo Y, Eubank DW, Stocco DM. Involvement of 5-lipoxygenase metabolites of arachidonic acid in cyclic AMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J Steroid Biochem Mol Biol 2003; 85:159-166.

38. Fiedler EP, Plouffe L, Hales DB, Hales KH, Khan I. Prostaglandin F2alpha induces a rapid decline in progesterone production and steroidogenic acute regulatory protein expression in isolated rat corpus luteum without altering messenger ribonucleic acid expression. Biol Reprod 1999; 61:643-650.

39. Diemer T, Allen JA, Hales KH, Hales DB. Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology 2003; 144:2882-2891.

40. Wang X, Shen CL, Dyson MT, Eimerl S, Orly J, Hutson JC, Stocco DM. Cyclooxygenase-2 regulation of the age-related decline in testosterone biosynthesis. Endocrinology 2005; 146:4202-4208.

41. Chen H, Cangello D, Benson S, Folmer J, Zhu H, Trush MA, Zirkin BR. Age-related increase in mitochondrial superoxide generation in the testosterone-producing cells of Brown Norway rat testes: relationship to reduced steroidogenic function? Exp Gerontol 2001; 36:1361-1373.

42. Sarel I, Widmaier EP. Stimulation of steroidogenesis in cultured rat adrenocortical cells by unsaturated fatty acids. Am J Physiol 1995; 268:R1484-R1490.

43. Matthys LA, Widmaier EP. Fatty acids inhibit adrenocorticotropininduced adrenal steroidogenesis. Horm Metab Res 1998; 30:80-88.

44. Chin EC, Naddafy JM, Cheng Z, Brickell JS, Wathes DC, Abayasekara DRE. Dietary polyunsaturated fatty acid supplementation in vivo modulates ovine adrenal steroidogenesis in vitro. Endocrine Abstr 2006; 11:P750. World Wide Web (URL: http://www.endocrine-abstracts.org/ea/0011/ea0011p750.htm). (April, 2007).

45. Mohn CE, Fernandez-Solari J, De Laurentiis A, Prestifilippo JP, de la Cal C, Funk R, Bornstein SR, McCann SM, Rettori V. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2. Proc Natl Acad Sci U S A 2005; 102:6213-6218.

46. Wu YL, Wiltbank MC. Transcriptional regulation of cyclooxygenase-2 gene in ovine large luteal cells. Biol Reprod 2001; 65:1565-1572.

47. Sayasith K, Bouchard N, Sawadogo M, Lussier JG, Sirois J. Molecular characterization and role of bovine upstream stimulatory factor 1 and 2 in the regulation of the prostaglandin G/H synthase-2 promoter in granulosa cells. J Biol Chem 2004; 279:6327-6336.

48. Michael AE, Webley GE. Prostaglandin F2a stimulates cAMP phosphodiesterase via protein kinase C in cultured human granulosa cells. Mol Cell Endocrinol 1991; 2:207-214.

49. Cheng Z, Sheldrick EL, Marshall E, Wathes DC, Abayasekara DRE, Flint APF. Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid. Reproduction 2007 (In Press).

50. German OL, Insua MF, Gentili C, Rotstein NP, Politi LE. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. J Neurochem 2006; 98:1507-1520.

51. Tsatsanis C, Androulidaki A, Venihaki M, Marqioris AN. Signalling networks regulating COX-2. Int J Biochem Cell Biol 2006; 38:1654-1661.

52. Sampath H, Ntambi JN. Polyunsaturated fatty acid regulation of genes and lipid metabolism. Annu Rev Nutr 2005; 25:317-340.

53. Cummins CL, Volle DH, Zhang Y, McDonald JG, Sion B, Lefrancois- Martinez A-M, Caira F, Veyssiere G, Mangelsdorf DJ, Lobaccaro J-MA. Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 2006; 116:1902-1912.

54. Hodges LM, Chin EC, Nadaffy JM, Brickell J, Cheng Z, Sheldrick EL, Flint APF, Wathes DC, Abayasekara DRE. Polyunsaturated fatty acids in vivo and in vitro affect expression of steroidogenic acute regulatory protein in steroidogenic tissues. Endocrine Abstr 2006; 12:P98. World Wide Web (URL: http://www.endocrine-abstracts.org/ea/0012/ea0012p98.htm). (April, 2007).

55. Gazouli M, Yao Z-X, Boujrad N, Corton JC, Culty M, Papadopoulos V.Effects of peroxisome proliferators on leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome receptoractivated receptor a. Endocrinology 2002; 143:2571-2583.

56. Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006; 189:199-209.

57. Jolly CA, Jiang Y-H, Chapkin RS, McMurray DN. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin- 2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 1997; 127:37-43.

58. Cheng Z, Abayasekara DRE, Wathes DC. The effect of supplementation with n-6 polyunsaturated fatty acids on 1-, 2- and 3- series prostaglandin F production by ovine uterine epithelial cells. Biochim Biophys Acta 2005; 1736:128-135.

59. Fahrenholz F, Klein U, Gimpl G. Conversion of the myometrial oxytocin receptor from low to high affinity state by cholesterol. Adv Exp Med Biol 1995; 395:311-319.

60. Hunter RH. Ageing of the unfertilized cow egg in vivo: how soon is fertility compromised? Vet Rec 1989; 124:489-490.

61. Miller BG, Moore NW, Murphy L, Stone GM. Early pregnancy in the ewe: effects of oestradiol and progesterone on uterine metabolism and on embryo survival. Aust J Biol Sci 1977; 30:279-288.

62. Roberts RM, Cross JC, Leaman DW. Interferons as hormones of pregnancy. Endocr Rev 1992; 13:432-452.

63. Santos JE, Thatcher WW, Chebel RC, Cerri RL, Galvao KN. The effect of embryonic death rates in cattle on the efficacy of estrus synchronization programs. Anim Reprod Sci 2004; 82-83:513-535.

64. McEvoy TG, Coull GD, Broadbent PJ, Hutchinson JS, Speake BK. Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida. J Reprod Fertil 2000; 118:163-170.

65. Adamiak SJ, Mackie K, Watt RG, Webb R, Sinclair KD. Impact of nutrition on oocyte quality: cumulative effects of body composition and diet leading to hyperinsulinemia in cattle. Biol Reprod 2005; 73:918-926.

66. Ferguson EM, Leese HJ. A potential role for triglyceride as an energy source during bovine oocyte maturation and early embryo development.Mol Reprod Dev 2006; 73:1195-1201.

67. Moallem U, Folman Y, Bor A, Arav A, Sklan D. Effect of calcium soaps of fatty acids and administration of somatotropin on milk production, preovulatory follicular development, and plasma and follicular fluid lipid composition in high yielding dairy cows. J Dairy Sci 1999; 82:2358-2368.

68. Kim JY, Kinoshita M, Oshnishi M, Fukui Y. Lipid and fatty acid analysis of fresh and frozen-thawed immature and in vitro matured bovine oocytes. Reproduction 2001; 122:131-138.

69. Zeron Y, Sklan D, Arav A. Effect of polyunsaturated fatty acid supplementation on biophysical parameters and chilling sensitivity of ewe oocytes. Mol Reprod Dev 2002; 61:271-278.

70. Bilby TR, Block J, do Amaral BC, Sa Filho O, Silvestre FT, Hansen PJ, Staples CR, Thatcher WW. Effects of dietary unsaturated fatty acids on oocyte quality and follicular development in lactating dairy cows in summer. J Dairy Sci 2006; 89:3891-3903.

71. Lucy MC, De la Sota RL, Staples CR, Thatcher WW. Ovarian follicular populations in lactating dairy cows treated with recombinant bovine somatotropin (Sometribove) or saline and fed diets differing in fat content and energy. J Dairy Sci 1993; 76:1014-1027.

72. Beam SW, Butler WR. Energy balance and ovarian follicle development prior to the first ovulation in dairy cows receiving three levels of dietary fat. Biol Reprod 1997; 56:133-142.

73. Bilby TR, Sozzi A, Lopez MM, Silvestre FT, Ealy AD, Staples CR, Thatcher WW. Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lacataing dairy cows: 1. Ovarian, conceptus, and growth hormone-insulin-like growth factor system responses. J Dairy Sci 2006;89:3360-3374.

74. Ambrose DJ, Kastelic JP, Corbett R, Pitney PA, Petit HV, Small JA, Zalkovic P. Lower pregnancy losses in lactating dairy cows fed a diet enriched in alpha-linolenic acid. J Dairy Sci 2006; 89:3066-3074.

75. Petit HV, Dewhurst RJ, Scollan ND, Proulx JG, Khalid M, Haresign W, Twagiramungu H, Mann GE. Milk production and composition, ovarian function and prostaglandin secretion of dairy cows fed omega-3 fatty acids. J Dairy Sci 2002; 85:889-899.

76. Petit HV, Germiquet C, Lebel D. Effect of feeding whole, unprocessed sunflower seeds and flaxseed on milk production, milk composition, and prostaglandin secretion in dairy cows. J Dairy Sci 2004; 87:3889-3898.

77. Wehrman ME, Welsh TH, Williams GL. Diet-induced hyperlipidemia in cattle modifies the intrafollicular cholesterol environment, modulates ovarian follicular dynamics, and hastens the onset of postpartum luteal activity. Biol Reprod 1991; 45:514-522.

78. Robinson RS, Pushpakumara PGA, Cheng Z, Peters AR, Abayasekara DRE, Wathes DC. Effects of dietary polyunsaturated fatty acids on ovarian and uterine function in lactating dairy cows. Reproduction 2002; 124:119-131.

79. Hinckley T, Clark RM, Bushmich SL, Milvae RA. Long chain polyunsaturated fatty acids and bovine luteal cell function. Biol Reprod 1996; 55:445-449.

80. Mattos R, Staples CR, Williams J, Amorocho A, McGuire MA, Thatcher WW. Uterine, ovarian, and production responses of lactating dairy cows to increasing dietary concentrations of menhaden fish meal. J Dairy Sci 2002; 85:755-764.

81. Weems YS, Bridges PJ, Tanaka Y, Sasser RG, LeaMaster BR, Vincent DL, Weems CW. PGE1 or PGE2 not LH regulates secretion of progesterone in vitro by the 88-90 day ovine corpus luteum of pregnancy. Prostaglandins 1997; 53:337-353.

82. Mattos R, Guzeloglu A, Badinga L, Staples CR, Thatcher WW.Polyunsaturated fatty acids and bovine interferon-tau modify phorbol ester-induced secretion of prostaglandin F2a and expression of prostaglandin endoperoxide synthase-2 and phospholipase A2 in bovine endometrial cells. Biol Reprod 2003; 69:780-787.

83. Naddafy JM, Chin EC, Cheng Z, Brickell JS, Wathes DC, Abayasekara DRE. Effects of dietary polyunsaturated fatty acids (PUFAs) on prostaglandin and progesterone secretion in the ewe. Reproduction Abstr Ser No 32. 2005; Abstract O05. World Wide Web (URL: http://www.srf-reproduction.org/meetings/fertility2005.pdf). (April, 2007).

84. Mann GE, Lamming GE, Payne JE. Role of early luteal phase progesterone in control of the timing of the luteolytic signal in cows. J Reprod Fertil 1998; 113:47-51.

85. Mattos R, Staples CR, Arteche A, Wiltbank MC, Diaz FJ, Jenkins TC, Thatcher WW. The Effects of feeding fish oil on uterine secretion of PGF2a, milk composition, and metabolic status of periparturient Holstein cows. J Dairy Sci 2004; 97:921-932.

86. Armstrong D, Goodall EA, Gordon FJ, Rice DA, McGaughey WJ. The effect of levels of concentrate offered and inclusion of maize gluten or fish meal in the concentrate on reproductive performance and blood parameters of dairy cows. Anim Prod 1990; 50:1-10.

87. Bruckental I, Drori D, Kaim M, Lehrer H, Folman Y. Effects of source and level of protein on milk yield and reproductive performance of highproducing primiparous and multiparous dairy cows. Anim Prod 1989; 48:319-329.

88. Burke JM, Staples CR, Risco CA, de la Sota RL, Thatcher WW. Effect of ruminant grade Menhaden fish meal on reproductive and productive performance of lactating dairy cows. J Dairy Sci 1997; 80:3386-3398.

89. Carroll DJ, Hossain FR, Keller MR. Effect of supplemental fish meal on the lactation and reproductive performance of dairy cows. J Dairy Sci 1994; 77:3058-3072.

90. Petit HV, Twagiramungu H. Conception rate and reproductive function of dairy cows fed different fat sources. Theriogenology 2006; 66:1316-1324.

91. Ambrose DJ, Estill CT, Colazo MG, Kastelic JP, Corbett R. Conception rates and pregnancy losses in dairy cows fed a diet supplemented with rolled flaxseed. In: Juengel JL, Murray JF, Smith MF (eds.), Reproduction in Domestic Ruminants VI. Nottingham: Nottingham University Press; 2006:500.

92. Early Pregnancy Tests.com [Internet]. c2007. Bellingham (WA): Kurkel Enterprises, LLC; [cited January 2007]. Available from: http://www.early-pregnancy-tests.com/epo.html

93. McFarlin BL, Gibson MH, O'Rear J, Harman P. A national survey of herbal preparation use by nurse-midwives for labor stimulation. J Nurse Midwifery 1999; 44:205-216.

94. Drug Digest [Internet]. c2007. St. Louis (MO): Express Scripts, Inc.; [cited January 2007]. Available from: http://www.drugdigest.org/DD/DVH/HerbsWho/0,3923,4010jEvening%20Primrose.00.html

95. Horrobin DF. Fatty-acid metabolism in health and disease-the role of delta-6-desaturase. Am J Clin Nutr 1993; 57:S732-S737.

96. Tocher DR, Bell JG, Farndale BM, Sargent JR. Effects of dietary gamma-linolenic acid-rich borage oil combined with marine fish oils on tissue phospholipid fatty acid composition and production of prostaglandins E and F of the 1-, 2- and 3-series in a marine fish deficient in delta 5 fatty acyl desaturase. Prostaglandins Leukot Essent Fatty Acids 1997; 57:125-134.

97. Cho HP, Nakamura MT, Clarke SD. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 1999; 274: 471-477.

98. Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999; 274: 37335-37339.

99. Ulmann L, Blond JP, Maniongui C, Poisson JP, Durand G, Bezard J, Pascal G. Effects of age and dietary essential fatty acids on desaturase activities and on fatty acid composition of liver microsomal phospholipids of adult rats. Lipids 1991; 26:127-133.

100. Chaud M, Franchi AM, Gimeno MF, Gimeno AL. Gamma-linolenic acid improves the constancy of contractions in uteri from sprayed rats and is metabolized to prostaglandin E1 but not to besenoic prostanoids. Prostaglandins 1988; 35:95-106.

101. Heath E, Weinstein P, Merritt B, Shanks R, Hixon J. Effects of prostaglandins on the bovine corpus luteum: granules, lipid inclusions and progesterone secretion. Biol Reprod 1983; 29:977-985.

102. Persaud TV. Pregnancy and progeny in rats treated with prostaglandin F1a. Prostaglandins Med 1980; 4:101-106.

103. Graham J, Franks S, Bonney RC. In vivo and in vitro effects of gammalinolenic acid and eicosapentaenoic acid on prostaglandin production and arachidonic acid uptake by human endometrium. Prostaglandins Leukot Essent Fatty Acids 1994; 50:321-329.

104. Caballero A, Garcia Albertos F, Corredera J, Alonso Magan JL. Prostaglandins PGF2a, E1 and F2a and delivery induction by intravenous infusion. Acta Ginecol (Madr) 1974; 25:23-54.

105. Tauson AH, Forsberg M. Effect of evening primrose oil as food supplement on reproduction in the blue fox. Acta Vet Scand 1991; 32:345-351.

106. Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, Whittle WL, Newnham JP. Prostaglandins and mechanisms of birth. Reproduction 2002; 124:1-17.

107. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21:514-550.

108. Olson DM. The role of prostaglandins in the initiation of parturition. Best Pract Res Clin Obstet Gynaecol 2003; 17:717-730.

109. Ogburn PL, Johnson SB, Williams PP, Holman RT. Levels of free fatty acids and arachidonic acid in pregnancy and labor. J Lab Clin Med 1980; 95:943-949.

110. Ashby AM, Robinette B, Kay HH. Plasma and erythrocyte profiles of nonesterified polyunsaturated fatty acids during normal pregnancy and labor. Am J Perinatol 1997; 14:623-629.

111. Reece MS, McGregor JA, Allen KG, Mathias MM, Harris MA. Prostaglandins in selected reproductive tissues in preterm and term gestations. Prostaglandins Leukot Essent Fatty Acids 1996; 55:303-307.

112. Reece MS, McGregor JA, Allen KG, Harris MA. Maternal and perinatal long-chain fatty acids: possible roles in preterm birth. Am J Obstet Gynecol 1997; 176:907-914.

113. Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br Med J 2002; 324:1-5.

114. Leat WMF, Northrop CA. Effect of linolenic acid on gestation and parturition in the rat. Progr Lipid Research 1981; 20:819-821.

115. Waltman R, Tricomi V, Shabanah EH, Arenas R. Prolongation of gestation time in rats by unsaturated fatty acids. Am J Obstet Gynecol 1977; 127:626-627.

116. Olsen SF, Hansen HS, Jensen B. Fish oil versus arachis oil food supplementation in relation to pregnancy duration in rats. Prostaglandins Leukot Essent Fatty Acids 1990; 40:255-260.

117. Olsen SF, Hansen HS, Sommer S, Jensen B, Sorensen TI, Secher NJ, Zachariassen P. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes; a study of women in the Faroe Islands and Denmark. Am J Obstet Gynecol 1991; 164:1203-1209.

118. Holman RT. Essential fatty acid deficiency. In: Holman RT (ed.), Progress in the Chemistry of Fats and Other Lipids. Oxford, UK:Pergamon Press; 1968:279-348.

119. Mathias MM, Tsai A, Harris MA, Mcgregor JA. Oral administration of menhaden oil alters gestation in rats. In: Lands WEM (ed.), Poyunsaturated Fatty Acids and Eicosanoids. Champaign, IL: American Oil Chemists' Society Press; 1987:508-512.

120. Leaver HA, Howie A, Wilson NH. The biosynthesis of the 3-series prostaglandins in rat uterus after alpha-linolenic acid feeding: mass spectroscopy of prostaglandins E and F produced by rat uteri in tissue culture. Prostaglandins Leukot Essent Fatty Acids 1991; 42:217-224.

121. Baguma-Nibasheka M, Brenna JT, Nathanialsz PW. Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates. Biol Reprod 1999; 60:698-701.

122. Ma XH, Wu WX, Brenna JT, Nathanielsz PW. Maternal intravenous administration of long-chain n-3 polyunsaturates to the pregnant ewe in late gestation results in specific inhibition of prostaglandin H synthase (PGHS)2, but not PGHS1 and oxytocin receptor mRNA in myometrium during betamethasone-induced labor. J Soc Gynecol Investig 2000; 7: 233-237.

123. Stark KD, Mulvad G, Pedersen HS, Park EJ, Dewailly E, Holub BJ. Fatty acid composition of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil. Nutrition 2002; 18:627-630.

124. Olsen S, Secher NJ. A possible preventative effect of low-fish oil on early delivery and pre-eclampsia: indications from a 50-year old controlled trial. Br J Nutr 1990; 64:599-609.

125. Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, Grant A. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992; 339:1003-1007.

126. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003; 101:469-479.

127. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team. BJOG 2000;107:382-395.

128. Borod E, Atkinson R, Barclay WR, Carlson SE. Effects of third trimester consumption of eggs high in docosahexaenoic acid on docosahexaenoic acid status and pregnancy. Lipids 1999; 34(suppl):S231.

129. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T,Drevon CA. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108/5/e82.

130. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol 2004; 160:774-783.

131. Lewin GA, Schachter HM, Yuen D, Merchant P, Mamaladze V, Tsertsvadze A. Effects of omega-3 fatty acids on child and maternal health. Evid Rep Technol Assess (Summ): No. 118. AHRQ Publication No. 05-E025-1. Rockville, MD: Agency for Healthcare Research and Quality; 2005.

132. Jones R, Mann T, Sherins RJ. Peroxidative breakdown of phospholipids in human spermatozoa: spermicidal effects of fatty acid peroxides and protective action of seminal plasma. Fertil Steril 1979; 31:531-537.

133. Alvarez JG, Storey BT. Differential incorporation of fatty acids into and peroxidative loss of fatty acids from phospholipids of human spermatozoa. Mol Reprod Dev 1995; 42:334-336.

134. Poulos A, Sharp P, Johnson D, White I, Fellenberg A. The occurrence of polyenoic fatty acids with greater than 22 carbon atoms in mammalian spermatozoa. Biochem J 1986; 240:891-895.

135. Surai PF, Blesbois E, Grasseau I, Chalah T, Brillard JP, Wishart GJ, Cerolini S, Sparks NH. Fatty acid composition, glutathione peroxidase and superoxide dismutase activity and total antioxidant activity of avian semen. Comp Biochem Physiol B Biochem Mol Biol 1998; 120:527-533.

136. Blesbois E, Lessire M, Grasseau I, Hallouis JM, Hermier D. Effect of dietary fat on the fatty acid composition and fertilizing ability of fowl semen. Biol Reprod 1997; 56:1216-1220.

137. Maldjian A, Pizzi F, Gliozzi T, Cerolini S, Penny P, Noble R. Changes in sperm quality and lipid composition during cryopreservation of boar semen. Theriogenology 2005; 63:411-421.

138. Zanini SF, Torres CA, Bragagnolo N, Turatti JM, Silva MG, Zanini MS. Evaluation of the ratio of omega-6: omega-3 fatty acids and vitamin E levels in the diet on the reproductive performance of cockerels. Arch Tierernahr 2003; 57:429-442.

139. Cerolini S, Surai PF, Speake BK, Sparks NH. Dietary fish and evening primrose oil with vitamin E effects on semen variables in cockerels. Br Poult Sci 2005; 46:214-222.

140. Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod 1989; 40: 183-187.

141. Aitken RJ, Harkiss D, Buckingham D. Relationship between ironcatalysed lipid peroxidation potential and human sperm function. J Reprod Fertil 1993; 98:257-265.

142. Aitken RJ, Harkiss D, Buckingham DW. Analysis of lipid peroxidation mechanisms in human spermatozoa. Mol Reprod Dev 1993; 35:302-315.

143. Gomez E, Irvine DS, Aitken RJ. Evaluation of a spectrophotometric assay for the measurement of malondialdehyde and 4-hydroxyalkenals in human spermatozoa: relationships with semen quality and sperm function. Int J Androl 1998; 21:81-94.

144. Kasimanickam R, Pelzer KD, Kasimanickam V, Swecker WS, Thatcher CD. Association of classical semen parameters, sperm DNA fragmentation index, lipid peroxidation and antioxidant enzymatic activity of semen in ram-lambs. Theriogenology 2006; 65:1407-1421.

145. Hsieh YY, Chang CC, Lin CS. Seminal malondialdehyde concentration but not glutathione peroxidase activity is negatively correlated with seminal concentration and motility. Int J Biol Sci 2006; 2:23-29.

146. Yesilli C, Mungan G, Seckiner I, Akduman B, Acikgoz S, Altan K, Mungan A. Effect of varicocelectomy on sperm creatine kinase, HspA2 chaperone protein (creatine kinase-M type), LDH, LDH-X, and lipid peroxidation product levels in infertile men with varicocele. Urology 2005; 66:610-615.

147. Arabi M, Moshtaghi H. Influence of cigarette smoking on spermatozoa via seminal plasma. Andrologia 2005; 37:119-124.

148. Naha N, Bhar RB, Mukherjee A, Chowdhury AR. Structural alteration of spermatozoa in the persons employed in lead acid battery factory. Indian J Physiol Pharmacol 2005; 49:153-162.

149. Levitas E, Lunenfeld E, Weiss N, Friger M, Har-Vardi I, Koifman A, Potashnik G. Relationship between the duration of sexual abstinence and semen quality: analysis of 9,489 semen samples. Fertil Steril 2005; 83: 1680-1686.

150. de Lamirande E, Leduc BE, Iwasaki A, Hassouna M, Gagnon C. Increased reactive oxygen species formation in semen of patients with spinal cord injury. Fertil Steril 1995; 63:637-642.

151. Aitken RJ, Buckingham DW, Brindle J, Gomez E, Baker HW, Irvine DS. Analysis of sperm movement in relation to the oxidative stress created by leukocytes in washed sperm preparations and seminal plasma. Hum Reprod 1995; 10:2061-2071.

152. Sharma RK, Pasqualotto AE, Nelson DR, Thomas AJ, Agarwal A. Relationship between seminal white blood cell counts and oxidative stress in men treated at an infertility clinic. J Androl 2001; 22:575-583.

153. van Overveld FW, Haenen GR, Rhemrev J, Vermeiden JP, Bast A. Tyrosine as important contributor to the antioxidant capacity of seminal plasma. Chem Biol Interact 2000; 127:151-161.

154. Rhemrev JP, van Overveld FW, Haenen GR, Teerlink T, Bast A, Vermeiden JP. Quantification of the nonenzymatic fast and slow TRAP in a post-addition assay in human seminal plasma and the antioxidant contributions of various seminal compounds. J Androl 2000; 21:913-920.

155. Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online 2004; 8:616-627.

156. Drevet JR. The antioxidant glutathione peroxidase family and spermatozoa: a complex story. Mol Cell Endocrinol 2006; 250:70-79.

157. Dacheux JL, Belghazi M, Lanson Y, Dacheux F. Human epididymal secretome and proteome. Mol Cell Endocrinol 2006; 250:36-42.

158. Sanocka D, Miesel R, Jedrzejczak P, Chelmonska-Soyta AC, Kurpisz M. Effect of reactive oxygen species and the activity of antioxidant systems on human semen; association with male infertility. Int J Androl 1997; 20: 255-264.

159. O WS, Chen H, Chow PH. Male genital tract antioxidant enzymes-their ability to preserve sperm DNA integrity. Mol Cell Endocrinol 2006; 250: 80-83.

160. Fraga CG, Motchnik PA, Wyrobek AJ, Rempel DM, Ames BN. Smoking and low antioxidant levels increase oxidative damage to sperm DNA. Mutat Res 1996; 351:199-203.

161. Saleh RA, Agarwal A, Sharma RK, Nelson DR, Thomas A. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study. Fertil Steril 2002; 78:491-499.

162. Suleiman SA, Elamin Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl 1996; 17:530-537.

163. Comhaire FH, el Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant ''Astaxanthin'' treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005; 7:257-262.

164. De Iuliis GN, Wingate JK, Koppers AJ, McLaughlin EA, Aitken RJ. Definitive evidence for the nonmitochondrial production of superoxide anion by human spermatozoa. J Clin Endocrinol Metab 2006; 91:1968-1975.

165. Ollero M, Gil-Guzman E, Lopez MC, Sharma RK, Agarwal A, Larson K, Evenson D, Thomas AJ, Alvarez JG. Characterization of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility. Hum Reprod 2001; 16:1912-1921.

166. Ollero M, Powers RD, Alvarez JG. Variation of docosahexaenoic acid content in subsets of human spermatozoa at different stages of maturation: implications for sperm lipoperoxidative damage. Mol Reprod Dev 2000; 55:326-334.

167. Aitken RJ, Wingate JK, De Iuliis GN, Koppers AJ, McLaughlin EA. Cisunsaturated fatty acids stimulate reactive oxygen species generation and lipid peroxidation in human spermatozoa. J Clin Endocrinol Metab 2006; 91:4154-4163.

168. Gomez E, Buckingham DW, Brindle J, Lanzafame F, Irvine DS, Aitken RJ. Development of an image analysis system to monitor the retention of residual cytoplasm by human spermatozoa: correlation with biochemical markers of the cytoplasmic space, oxidative stress, and sperm function. J Androl 1996; 17:276-287.

169. Pasqualotto FF, Sharma RK, Nelson DR, Thomas AJ, Agarwal A. Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation. Fertil Steril 2000;73:459-464.

170. Mitre R, Cheminade C, Allaume P, Legrand P, Legrand AB. Oral intake of shark liver oil modifies lipid composition and improves motility and velocity of boar sperm. Theriogenology 2004; 62:1557-1566.

171. Paulenz H, Taugbol O, Hofmo PO, Saarem K. A preliminary study on the effect of dietary supplementation with cod liver oil on the polyunsaturated fatty acid composition of boar semen. Vet Res Commun 1995; 19: 273-284.